Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 84 | 2024 | 449 | 13.730 |
Why?
|
Retinal Neovascularization | 35 | 2024 | 288 | 8.090 |
Why?
|
Retinal Vessels | 37 | 2024 | 849 | 4.320 |
Why?
|
Choroidal Neovascularization | 10 | 2024 | 350 | 3.580 |
Why?
|
Retina | 35 | 2024 | 2648 | 3.100 |
Why?
|
Insulin-Like Growth Factor I | 35 | 2021 | 1936 | 2.830 |
Why?
|
Fatty Acids, Omega-3 | 17 | 2024 | 1396 | 2.760 |
Why?
|
Neovascularization, Pathologic | 23 | 2021 | 2630 | 2.540 |
Why?
|
Infant, Premature | 37 | 2024 | 2120 | 2.360 |
Why?
|
Vascular Endothelial Growth Factor A | 51 | 2024 | 3504 | 2.140 |
Why?
|
Macular Degeneration | 11 | 2022 | 1001 | 2.030 |
Why?
|
Retinal Diseases | 11 | 2024 | 702 | 1.940 |
Why?
|
Angiogenesis Inhibitors | 15 | 2024 | 2046 | 1.670 |
Why?
|
Oxygen | 29 | 2024 | 4242 | 1.670 |
Why?
|
Neovascularization, Physiologic | 11 | 2020 | 1377 | 1.620 |
Why?
|
Infant, Newborn | 94 | 2024 | 26332 | 1.350 |
Why?
|
Photoreceptor Cells, Vertebrate | 4 | 2021 | 203 | 1.240 |
Why?
|
Adiponectin | 5 | 2022 | 1120 | 1.240 |
Why?
|
Retinal Neurons | 5 | 2018 | 66 | 1.200 |
Why?
|
Endothelial Growth Factors | 15 | 2003 | 680 | 1.190 |
Why?
|
Fibroblast Growth Factors | 3 | 2020 | 871 | 1.190 |
Why?
|
Disease Models, Animal | 40 | 2024 | 18289 | 1.160 |
Why?
|
Diabetic Retinopathy | 7 | 2020 | 1295 | 1.120 |
Why?
|
Fatty Acids | 7 | 2023 | 1806 | 1.110 |
Why?
|
Erythropoietin | 9 | 2018 | 716 | 1.090 |
Why?
|
Choroid | 3 | 2020 | 352 | 1.080 |
Why?
|
Docosahexaenoic Acids | 9 | 2024 | 916 | 1.080 |
Why?
|
Arachidonic Acid | 8 | 2024 | 430 | 1.040 |
Why?
|
Lymphokines | 14 | 2003 | 911 | 1.000 |
Why?
|
Vascular Endothelial Growth Factors | 17 | 2016 | 754 | 0.930 |
Why?
|
Biological Assay | 2 | 2020 | 627 | 0.910 |
Why?
|
Microvessels | 3 | 2020 | 589 | 0.900 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 3 | 2024 | 178 | 0.900 |
Why?
|
Hyperglycemia | 3 | 2023 | 1392 | 0.890 |
Why?
|
Gestational Age | 35 | 2023 | 3612 | 0.890 |
Why?
|
Animals | 106 | 2024 | 168731 | 0.890 |
Why?
|
Mice | 79 | 2024 | 81792 | 0.890 |
Why?
|
Receptors, LDL | 4 | 2017 | 491 | 0.870 |
Why?
|
Ophthalmology | 5 | 2017 | 560 | 0.870 |
Why?
|
Mice, Inbred C57BL | 44 | 2024 | 22321 | 0.860 |
Why?
|
Receptor, IGF Type 1 | 3 | 2016 | 385 | 0.850 |
Why?
|
Laser Coagulation | 5 | 2024 | 334 | 0.840 |
Why?
|
Ophthalmic Solutions | 1 | 2024 | 312 | 0.840 |
Why?
|
Photoreceptor Cells | 3 | 2021 | 234 | 0.830 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2020 | 1241 | 0.800 |
Why?
|
Birth Weight | 14 | 2021 | 2121 | 0.750 |
Why?
|
Antioxidants | 2 | 2024 | 1670 | 0.730 |
Why?
|
Propranolol | 2 | 2012 | 494 | 0.710 |
Why?
|
Weight Gain | 10 | 2017 | 2355 | 0.610 |
Why?
|
Fluorescein Angiography | 6 | 2019 | 1050 | 0.600 |
Why?
|
Ischemia | 8 | 2024 | 1910 | 0.580 |
Why?
|
Oxidation-Reduction | 3 | 2021 | 2218 | 0.580 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 8 | 2021 | 416 | 0.570 |
Why?
|
Neuroglia | 3 | 2024 | 964 | 0.570 |
Why?
|
Sirtuin 1 | 3 | 2014 | 246 | 0.570 |
Why?
|
Endothelium, Vascular | 13 | 2020 | 4423 | 0.560 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 15 | 2012 | 4563 | 0.540 |
Why?
|
Dexamethasone | 1 | 2024 | 1964 | 0.540 |
Why?
|
Neonatal Screening | 9 | 2024 | 619 | 0.540 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2012 | 1238 | 0.530 |
Why?
|
Capillary Permeability | 2 | 2020 | 767 | 0.530 |
Why?
|
Mitochondria | 3 | 2024 | 3670 | 0.520 |
Why?
|
Fenofibrate | 1 | 2016 | 86 | 0.520 |
Why?
|
Premature Birth | 4 | 2022 | 1829 | 0.510 |
Why?
|
Dietary Supplements | 4 | 2024 | 3425 | 0.510 |
Why?
|
Fatty Acids, Unsaturated | 5 | 2022 | 538 | 0.490 |
Why?
|
Endothelial Cells | 15 | 2022 | 3584 | 0.490 |
Why?
|
Signal Transduction | 13 | 2020 | 23589 | 0.470 |
Why?
|
Animals, Newborn | 11 | 2016 | 2670 | 0.470 |
Why?
|
Acetates | 1 | 2016 | 314 | 0.470 |
Why?
|
Infant, Low Birth Weight | 6 | 2019 | 870 | 0.470 |
Why?
|
Frizzled Receptors | 2 | 2012 | 86 | 0.460 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1807 | 0.460 |
Why?
|
RNA, Messenger | 20 | 2014 | 12769 | 0.460 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 576 | 0.460 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 423 | 0.450 |
Why?
|
Fetal Development | 2 | 2016 | 777 | 0.440 |
Why?
|
Optic Nerve Diseases | 1 | 2017 | 342 | 0.420 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 3 | 2009 | 207 | 0.420 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2014 | 246 | 0.410 |
Why?
|
Humans | 144 | 2024 | 765734 | 0.400 |
Why?
|
Mice, Knockout | 15 | 2024 | 14445 | 0.390 |
Why?
|
Vitreous Body | 4 | 2020 | 399 | 0.390 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2012 | 106 | 0.390 |
Why?
|
Lipid Metabolism | 4 | 2017 | 1892 | 0.390 |
Why?
|
Optic Disk Drusen | 1 | 2012 | 38 | 0.390 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1118 | 0.380 |
Why?
|
Goals | 1 | 2017 | 719 | 0.380 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 3 | 2003 | 561 | 0.370 |
Why?
|
Receptors, Growth Factor | 4 | 2002 | 324 | 0.370 |
Why?
|
Stilbenes | 2 | 2014 | 154 | 0.370 |
Why?
|
Milk, Human | 4 | 2024 | 490 | 0.370 |
Why?
|
Retinal Telangiectasis | 1 | 2011 | 25 | 0.360 |
Why?
|
Research | 1 | 2019 | 1975 | 0.360 |
Why?
|
Quinolines | 1 | 2016 | 769 | 0.360 |
Why?
|
PPAR gamma | 2 | 2011 | 483 | 0.350 |
Why?
|
Interleukin-18 | 1 | 2012 | 251 | 0.350 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2011 | 128 | 0.350 |
Why?
|
Visual Acuity | 3 | 2019 | 2672 | 0.340 |
Why?
|
Sphingolipids | 2 | 2022 | 177 | 0.340 |
Why?
|
Blindness | 4 | 2020 | 587 | 0.340 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9522 | 0.340 |
Why?
|
Complement System Proteins | 1 | 2013 | 714 | 0.330 |
Why?
|
Retinitis Pigmentosa | 2 | 2021 | 391 | 0.330 |
Why?
|
Eye | 3 | 2016 | 710 | 0.320 |
Why?
|
Regeneration | 3 | 2013 | 1517 | 0.320 |
Why?
|
Energy Metabolism | 2 | 2021 | 2891 | 0.320 |
Why?
|
DNA Primers | 5 | 2008 | 2823 | 0.320 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 556 | 0.310 |
Why?
|
Heat-Shock Proteins | 1 | 2013 | 790 | 0.310 |
Why?
|
Cell Proliferation | 8 | 2017 | 10428 | 0.310 |
Why?
|
Receptor Protein-Tyrosine Kinases | 5 | 2012 | 1622 | 0.300 |
Why?
|
Dietary Fats | 4 | 2021 | 2002 | 0.290 |
Why?
|
Blotting, Western | 8 | 2017 | 5019 | 0.290 |
Why?
|
Hyperoxia | 6 | 2024 | 260 | 0.290 |
Why?
|
Monocytes | 2 | 2014 | 2594 | 0.280 |
Why?
|
Fatty Acids, Omega-6 | 3 | 2018 | 226 | 0.280 |
Why?
|
Infant | 25 | 2023 | 36363 | 0.280 |
Why?
|
Eye Proteins | 5 | 2016 | 628 | 0.270 |
Why?
|
Carrier Proteins | 4 | 2021 | 4912 | 0.260 |
Why?
|
Fat Emulsions, Intravenous | 3 | 2018 | 314 | 0.260 |
Why?
|
Gene Expression Regulation | 10 | 2021 | 11888 | 0.260 |
Why?
|
RNA, Small Interfering | 3 | 2017 | 3419 | 0.250 |
Why?
|
PPAR alpha | 2 | 2017 | 176 | 0.250 |
Why?
|
Eye Diseases | 2 | 2010 | 659 | 0.250 |
Why?
|
Angiopoietin-1 | 3 | 2012 | 132 | 0.240 |
Why?
|
Infant, Premature, Diseases | 2 | 2022 | 712 | 0.240 |
Why?
|
Nerve Tissue Proteins | 6 | 2017 | 4391 | 0.240 |
Why?
|
Neurons | 6 | 2017 | 9521 | 0.240 |
Why?
|
Retinal Ganglion Cells | 5 | 2013 | 810 | 0.240 |
Why?
|
Adiposity | 1 | 2015 | 1891 | 0.240 |
Why?
|
Recombinant Proteins | 6 | 2021 | 6492 | 0.240 |
Why?
|
Receptor, Insulin | 1 | 2008 | 837 | 0.230 |
Why?
|
Retinal Degeneration | 3 | 2021 | 413 | 0.230 |
Why?
|
Fundus Oculi | 5 | 2019 | 543 | 0.230 |
Why?
|
Receptors, Chemokine | 1 | 2007 | 651 | 0.230 |
Why?
|
Bronchopulmonary Dysplasia | 5 | 2018 | 329 | 0.220 |
Why?
|
Male | 65 | 2024 | 363585 | 0.220 |
Why?
|
Fluorescent Antibody Technique, Indirect | 4 | 2019 | 425 | 0.220 |
Why?
|
Female | 71 | 2024 | 395961 | 0.220 |
Why?
|
Cells, Cultured | 11 | 2020 | 18972 | 0.210 |
Why?
|
Nerve Growth Factors | 4 | 2016 | 564 | 0.210 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3446 | 0.210 |
Why?
|
Parenteral Nutrition | 4 | 2024 | 660 | 0.210 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15883 | 0.210 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2004 | 184 | 0.210 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8038 | 0.210 |
Why?
|
Decision Support Systems, Clinical | 2 | 2023 | 1175 | 0.210 |
Why?
|
Flunarizine | 1 | 2022 | 8 | 0.210 |
Why?
|
Mice, Transgenic | 6 | 2016 | 9548 | 0.200 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2015 | 548 | 0.200 |
Why?
|
Inflammation | 3 | 2024 | 10846 | 0.200 |
Why?
|
NADPH-Ferrihemoprotein Reductase | 1 | 2022 | 30 | 0.200 |
Why?
|
Macrophages | 3 | 2014 | 5772 | 0.200 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2022 | 41 | 0.200 |
Why?
|
Sphingosine | 2 | 2023 | 306 | 0.200 |
Why?
|
Administration, Topical | 1 | 2024 | 703 | 0.200 |
Why?
|
Sweden | 7 | 2021 | 1381 | 0.200 |
Why?
|
Lysophospholipids | 2 | 2023 | 335 | 0.200 |
Why?
|
Pregnancy Proteins | 1 | 2003 | 225 | 0.200 |
Why?
|
Angiopoietin-2 | 3 | 2012 | 187 | 0.190 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4036 | 0.190 |
Why?
|
Risk Factors | 24 | 2024 | 74831 | 0.190 |
Why?
|
Gene Dosage | 2 | 2005 | 1213 | 0.190 |
Why?
|
Infant, Very Low Birth Weight | 4 | 2020 | 409 | 0.190 |
Why?
|
Peptide Nucleic Acids | 1 | 2021 | 28 | 0.180 |
Why?
|
Vision, Ocular | 1 | 2004 | 457 | 0.180 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2012 | 658 | 0.180 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2016 | 418 | 0.180 |
Why?
|
Enteral Nutrition | 3 | 2024 | 803 | 0.180 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2001 | 80 | 0.180 |
Why?
|
Botulinum Toxins, Type A | 1 | 2024 | 239 | 0.180 |
Why?
|
STAT3 Transcription Factor | 2 | 2017 | 871 | 0.180 |
Why?
|
Stem Cell Transplantation | 2 | 2010 | 1601 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2017 | 4352 | 0.170 |
Why?
|
Transcription Factors | 5 | 2020 | 12123 | 0.170 |
Why?
|
Receptor, TIE-2 | 4 | 2014 | 183 | 0.170 |
Why?
|
Blood-Retinal Barrier | 1 | 2020 | 62 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2018 | 10730 | 0.170 |
Why?
|
Transcription Factor AP-1 | 2 | 2020 | 322 | 0.160 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 502 | 0.150 |
Why?
|
Microglia | 1 | 2007 | 1371 | 0.150 |
Why?
|
Models, Biological | 2 | 2013 | 9441 | 0.150 |
Why?
|
Transcription, Genetic | 5 | 2017 | 7599 | 0.150 |
Why?
|
Intravitreal Injections | 5 | 2022 | 391 | 0.150 |
Why?
|
Polymerase Chain Reaction | 4 | 2019 | 6061 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2001 | 422 | 0.150 |
Why?
|
Receptors, Erythropoietin | 2 | 2008 | 145 | 0.150 |
Why?
|
Interleukin-6 | 3 | 2017 | 3229 | 0.150 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2019 | 148 | 0.150 |
Why?
|
Leukocytosis | 1 | 2019 | 248 | 0.140 |
Why?
|
Sturge-Weber Syndrome | 1 | 2019 | 87 | 0.140 |
Why?
|
Choroid Neoplasms | 1 | 2019 | 175 | 0.140 |
Why?
|
National Eye Institute (U.S.) | 1 | 2017 | 5 | 0.140 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2017 | 65 | 0.140 |
Why?
|
Oligonucleotides, Antisense | 2 | 1999 | 462 | 0.140 |
Why?
|
Receptors, Adiponectin | 1 | 2017 | 82 | 0.140 |
Why?
|
Cell Hypoxia | 3 | 2014 | 646 | 0.140 |
Why?
|
Infant Mortality | 1 | 2022 | 752 | 0.140 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 2412 | 0.140 |
Why?
|
Retinoids | 1 | 2017 | 99 | 0.130 |
Why?
|
Pregnancy | 11 | 2022 | 30248 | 0.130 |
Why?
|
Transforming Growth Factor beta | 2 | 2004 | 1994 | 0.130 |
Why?
|
NF-kappa B | 2 | 2020 | 2486 | 0.130 |
Why?
|
Up-Regulation | 4 | 2013 | 4136 | 0.130 |
Why?
|
3T3-L1 Cells | 2 | 2015 | 206 | 0.130 |
Why?
|
Electroretinography | 1 | 2018 | 524 | 0.130 |
Why?
|
Conjunctivitis, Viral | 1 | 1995 | 6 | 0.130 |
Why?
|
Ketoglutaric Acids | 1 | 2016 | 75 | 0.130 |
Why?
|
Volatilization | 1 | 2015 | 75 | 0.120 |
Why?
|
Capillaries | 1 | 2019 | 751 | 0.120 |
Why?
|
Sulfides | 1 | 2016 | 166 | 0.120 |
Why?
|
Bruch Membrane | 1 | 2015 | 62 | 0.120 |
Why?
|
Conjunctivitis, Bacterial | 1 | 1995 | 22 | 0.120 |
Why?
|
Lasers | 2 | 2017 | 951 | 0.120 |
Why?
|
Tissue Culture Techniques | 1 | 2016 | 286 | 0.120 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2018 | 385 | 0.120 |
Why?
|
Growth Hormone | 1 | 1997 | 567 | 0.120 |
Why?
|
Diet | 4 | 2018 | 8085 | 0.120 |
Why?
|
Matrix Metalloproteinases | 1 | 2017 | 392 | 0.120 |
Why?
|
Pyrroles | 1 | 2001 | 1119 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 2 | 2012 | 4520 | 0.120 |
Why?
|
Cyclopropanes | 1 | 2016 | 437 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2012 | 3794 | 0.120 |
Why?
|
Lipoxygenase | 1 | 2014 | 71 | 0.110 |
Why?
|
Interleukin-1beta | 2 | 2018 | 1027 | 0.110 |
Why?
|
Biotransformation | 1 | 2014 | 165 | 0.110 |
Why?
|
Proteome | 1 | 2024 | 1897 | 0.110 |
Why?
|
Cattle | 5 | 2003 | 3800 | 0.110 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2016 | 457 | 0.110 |
Why?
|
Hemangioma | 1 | 2019 | 723 | 0.110 |
Why?
|
Light | 2 | 1994 | 1364 | 0.110 |
Why?
|
Angiostatic Proteins | 1 | 2013 | 2 | 0.110 |
Why?
|
Cerebral Hemorrhage | 3 | 2018 | 2649 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 2 | 2004 | 3406 | 0.110 |
Why?
|
Administration, Oral | 2 | 2012 | 4015 | 0.110 |
Why?
|
Indoles | 2 | 2001 | 1832 | 0.110 |
Why?
|
Retinal Pigment Epithelium | 2 | 2013 | 298 | 0.110 |
Why?
|
Plasma | 1 | 2017 | 579 | 0.110 |
Why?
|
Retinal Photoreceptor Cell Outer Segment | 1 | 2013 | 13 | 0.110 |
Why?
|
Fish Oils | 1 | 2017 | 483 | 0.110 |
Why?
|
Integrases | 2 | 2014 | 520 | 0.110 |
Why?
|
Laser Therapy | 3 | 2015 | 1108 | 0.110 |
Why?
|
Epoxide Hydrolases | 1 | 2014 | 122 | 0.110 |
Why?
|
Vascular Malformations | 1 | 2019 | 470 | 0.110 |
Why?
|
Membrane Proteins | 3 | 2017 | 7849 | 0.100 |
Why?
|
Angiogenic Proteins | 1 | 2013 | 101 | 0.100 |
Why?
|
Retrospective Studies | 17 | 2024 | 81457 | 0.100 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2014 | 318 | 0.100 |
Why?
|
Aorta | 3 | 2016 | 2027 | 0.100 |
Why?
|
Apolipoproteins | 1 | 2015 | 327 | 0.100 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 2011 | 564 | 0.100 |
Why?
|
Platelet Count | 3 | 2021 | 782 | 0.100 |
Why?
|
Hemoglobins | 1 | 2018 | 1528 | 0.100 |
Why?
|
Wet Macular Degeneration | 1 | 2014 | 158 | 0.100 |
Why?
|
Human Growth Hormone | 3 | 2007 | 639 | 0.100 |
Why?
|
Dependovirus | 1 | 2017 | 721 | 0.100 |
Why?
|
Lipids | 1 | 2023 | 3315 | 0.100 |
Why?
|
Amino Acid Transport Systems, Neutral | 1 | 2012 | 42 | 0.100 |
Why?
|
Adipose Tissue, White | 1 | 2015 | 371 | 0.100 |
Why?
|
In Situ Hybridization | 4 | 2002 | 1885 | 0.100 |
Why?
|
Receptors, Ghrelin | 1 | 2011 | 20 | 0.100 |
Why?
|
Insulator Elements | 1 | 2011 | 27 | 0.100 |
Why?
|
Injections, Intraperitoneal | 1 | 2012 | 411 | 0.090 |
Why?
|
Carbazoles | 1 | 2013 | 229 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 3805 | 0.090 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2013 | 254 | 0.090 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2012 | 242 | 0.090 |
Why?
|
Culture Media | 1 | 2013 | 889 | 0.090 |
Why?
|
Semaphorin-3A | 1 | 2011 | 39 | 0.090 |
Why?
|
Cell Survival | 1 | 2001 | 5747 | 0.090 |
Why?
|
Metabolomics | 1 | 2020 | 1668 | 0.090 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2012 | 75 | 0.090 |
Why?
|
Nerve Degeneration | 2 | 2014 | 748 | 0.090 |
Why?
|
Organ Culture Techniques | 1 | 2013 | 788 | 0.090 |
Why?
|
Tomography, Optical Coherence | 3 | 2021 | 2878 | 0.090 |
Why?
|
Pericytes | 1 | 2013 | 299 | 0.090 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 682 | 0.090 |
Why?
|
Cyclooxygenase 2 | 2 | 2011 | 594 | 0.090 |
Why?
|
Telangiectasis | 1 | 2010 | 77 | 0.090 |
Why?
|
Molecular Chaperones | 1 | 2015 | 762 | 0.090 |
Why?
|
Breast Feeding | 1 | 2019 | 1363 | 0.090 |
Why?
|
ROC Curve | 4 | 2020 | 3618 | 0.090 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 752 | 0.090 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 1995 | 537 | 0.090 |
Why?
|
Stem Cell Research | 1 | 2010 | 36 | 0.090 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2010 | 186 | 0.090 |
Why?
|
Lipid Peroxidation | 1 | 2011 | 275 | 0.080 |
Why?
|
Infusions, Intravenous | 4 | 2018 | 2229 | 0.080 |
Why?
|
Serpins | 2 | 2016 | 244 | 0.080 |
Why?
|
Eicosapentaenoic Acid | 1 | 2014 | 565 | 0.080 |
Why?
|
Calpain | 1 | 2010 | 145 | 0.080 |
Why?
|
RNA | 3 | 2012 | 2717 | 0.080 |
Why?
|
Reference Standards | 1 | 2013 | 1013 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2020 | 3606 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 2 | 2017 | 1959 | 0.080 |
Why?
|
Macula Lutea | 1 | 2010 | 168 | 0.080 |
Why?
|
Ghrelin | 1 | 2011 | 255 | 0.080 |
Why?
|
Pulmonary Alveoli | 1 | 2012 | 664 | 0.080 |
Why?
|
Fluoresceins | 3 | 1994 | 234 | 0.080 |
Why?
|
Cryosurgery | 1 | 2014 | 479 | 0.080 |
Why?
|
Retinal Vein Occlusion | 1 | 2010 | 147 | 0.080 |
Why?
|
Developmental Disabilities | 1 | 2018 | 1519 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2454 | 0.080 |
Why?
|
Longitudinal Studies | 5 | 2018 | 14745 | 0.080 |
Why?
|
Zinc Fingers | 1 | 2011 | 576 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 1992 | 593 | 0.080 |
Why?
|
Receptor, IGF Type 2 | 1 | 2008 | 35 | 0.080 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2024 | 352 | 0.080 |
Why?
|
Anemia | 1 | 2018 | 1510 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1404 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1885 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 2 | 2014 | 3737 | 0.080 |
Why?
|
Long-Term Potentiation | 1 | 2010 | 290 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 3 | 2017 | 8102 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2016 | 1171 | 0.080 |
Why?
|
Leptin | 2 | 2015 | 1597 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 414 | 0.080 |
Why?
|
Anemia, Neonatal | 1 | 2008 | 19 | 0.080 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2010 | 251 | 0.070 |
Why?
|
Sentinel Surveillance | 1 | 2010 | 292 | 0.070 |
Why?
|
Microscopy, Confocal | 2 | 2017 | 1965 | 0.070 |
Why?
|
Dissection | 1 | 2009 | 299 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2012 | 722 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11007 | 0.070 |
Why?
|
Prospective Studies | 10 | 2021 | 54795 | 0.070 |
Why?
|
Dextrans | 3 | 1994 | 570 | 0.070 |
Why?
|
Prognosis | 5 | 2023 | 29899 | 0.070 |
Why?
|
Algorithms | 8 | 2013 | 14061 | 0.070 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1138 | 0.070 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2008 | 271 | 0.070 |
Why?
|
Rats | 6 | 2017 | 23704 | 0.070 |
Why?
|
Phospholipids | 2 | 2023 | 776 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2012 | 1332 | 0.070 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2007 | 125 | 0.070 |
Why?
|
Maternal-Fetal Exchange | 1 | 2009 | 453 | 0.070 |
Why?
|
Parturition | 1 | 2010 | 453 | 0.070 |
Why?
|
Enterocolitis, Necrotizing | 2 | 2016 | 328 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 16041 | 0.070 |
Why?
|
DNA Repair | 1 | 2016 | 2051 | 0.070 |
Why?
|
Macular Edema | 1 | 2010 | 384 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2001 | 1240 | 0.060 |
Why?
|
Cell Line | 4 | 2013 | 15542 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2817 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 18061 | 0.060 |
Why?
|
Injections | 1 | 2008 | 839 | 0.060 |
Why?
|
Free Radicals | 1 | 2005 | 238 | 0.060 |
Why?
|
Tissue Distribution | 3 | 2010 | 2266 | 0.060 |
Why?
|
Arachidonic Acids | 1 | 2005 | 293 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59459 | 0.060 |
Why?
|
Phenotype | 4 | 2016 | 16706 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2794 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7424 | 0.060 |
Why?
|
Fetal Growth Retardation | 2 | 2011 | 591 | 0.060 |
Why?
|
Chromatin | 2 | 2017 | 2981 | 0.060 |
Why?
|
Astrocytes | 2 | 2021 | 1345 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1747 | 0.060 |
Why?
|
False Positive Reactions | 3 | 2012 | 955 | 0.060 |
Why?
|
Thrombospondin 1 | 1 | 2005 | 256 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4334 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5753 | 0.060 |
Why?
|
Awards and Prizes | 1 | 2008 | 364 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2024 | 205 | 0.050 |
Why?
|
Repressor Proteins | 2 | 2011 | 2968 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2056 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2005 | 462 | 0.050 |
Why?
|
Lymphatic Abnormalities | 1 | 2005 | 134 | 0.050 |
Why?
|
Aging | 2 | 2013 | 8730 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2012 | 2445 | 0.050 |
Why?
|
Glycoproteins | 1 | 2010 | 2194 | 0.050 |
Why?
|
Visual Cortex | 1 | 2010 | 1084 | 0.050 |
Why?
|
Sepsis | 1 | 2016 | 2601 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 911 | 0.050 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2005 | 707 | 0.050 |
Why?
|
Optic Nerve | 3 | 2001 | 568 | 0.050 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2023 | 121 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2013 | 20120 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2010 | 1159 | 0.050 |
Why?
|
Mass Spectrometry | 2 | 2020 | 2194 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2005 | 636 | 0.050 |
Why?
|
Visual Perception | 1 | 2010 | 1394 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2005 | 1984 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 13024 | 0.050 |
Why?
|
Brain | 3 | 2018 | 27178 | 0.050 |
Why?
|
Child Development | 3 | 2018 | 2326 | 0.050 |
Why?
|
Orbit | 1 | 2005 | 458 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2896 | 0.050 |
Why?
|
Growth Disorders | 1 | 2006 | 633 | 0.050 |
Why?
|
Ceramides | 1 | 2022 | 201 | 0.050 |
Why?
|
Extracellular Matrix | 3 | 2017 | 1727 | 0.050 |
Why?
|
Learning | 1 | 2010 | 1755 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2021 | 12433 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3691 | 0.040 |
Why?
|
Cohort Studies | 4 | 2023 | 41631 | 0.040 |
Why?
|
Disease Progression | 3 | 2013 | 13614 | 0.040 |
Why?
|
Oximetry | 2 | 2016 | 459 | 0.040 |
Why?
|
Memory | 1 | 2010 | 2191 | 0.040 |
Why?
|
Axonal Transport | 1 | 2001 | 178 | 0.040 |
Why?
|
Receptor, trkB | 1 | 2001 | 122 | 0.040 |
Why?
|
Head | 1 | 2006 | 925 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2008 | 2354 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2004 | 701 | 0.040 |
Why?
|
RNA Interference | 1 | 2008 | 2828 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2709 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2021 | 416 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2003 | 637 | 0.040 |
Why?
|
Blotting, Northern | 2 | 2003 | 1546 | 0.040 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2002 | 498 | 0.040 |
Why?
|
United States | 3 | 2017 | 72898 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2021 | 508 | 0.040 |
Why?
|
Base Sequence | 3 | 2001 | 12402 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1657 | 0.040 |
Why?
|
Dimerization | 1 | 2001 | 880 | 0.040 |
Why?
|
Child | 8 | 2022 | 80499 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2002 | 11080 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2016 | 614 | 0.040 |
Why?
|
Hypothalamus | 1 | 1984 | 995 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 869 | 0.040 |
Why?
|
Time Factors | 4 | 2016 | 40066 | 0.040 |
Why?
|
Cell Movement | 3 | 2017 | 5192 | 0.040 |
Why?
|
Cesarean Section | 2 | 2022 | 1431 | 0.040 |
Why?
|
Serine | 1 | 2022 | 824 | 0.040 |
Why?
|
Face | 1 | 2005 | 1028 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9594 | 0.040 |
Why?
|
Creatine | 1 | 2020 | 424 | 0.040 |
Why?
|
Vision Disorders | 2 | 2022 | 1087 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2023 | 674 | 0.040 |
Why?
|
Growth Inhibitors | 1 | 1999 | 375 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 1 | 2019 | 185 | 0.040 |
Why?
|
Acetaminophen | 1 | 2022 | 548 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2004 | 1154 | 0.040 |
Why?
|
Aged | 8 | 2020 | 171050 | 0.040 |
Why?
|
Chromatography, Gas | 1 | 2018 | 151 | 0.040 |
Why?
|
Developing Countries | 1 | 2010 | 2912 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1869 | 0.040 |
Why?
|
Hippocampus | 1 | 2010 | 3774 | 0.040 |
Why?
|
Pilot Projects | 3 | 2018 | 8732 | 0.040 |
Why?
|
Triplets | 1 | 1997 | 42 | 0.040 |
Why?
|
Transfection | 1 | 2005 | 5744 | 0.040 |
Why?
|
Radioimmunoassay | 2 | 2009 | 860 | 0.040 |
Why?
|
Soybean Oil | 1 | 2018 | 139 | 0.030 |
Why?
|
Plant Oils | 1 | 2018 | 199 | 0.030 |
Why?
|
Hormone Antagonists | 1 | 1997 | 108 | 0.030 |
Why?
|
Sensitivity and Specificity | 5 | 2012 | 14637 | 0.030 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2021 | 605 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1526 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2021 | 65180 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2019 | 4106 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2005 | 2143 | 0.030 |
Why?
|
Morbidity | 1 | 2022 | 1749 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2001 | 1059 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 597 | 0.030 |
Why?
|
Mutation | 3 | 2019 | 30184 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2001 | 1718 | 0.030 |
Why?
|
Child, Preschool | 5 | 2016 | 42468 | 0.030 |
Why?
|
Societies, Medical | 1 | 2008 | 3955 | 0.030 |
Why?
|
Semaphorins | 1 | 2016 | 96 | 0.030 |
Why?
|
Dental Enamel Hypoplasia | 1 | 1995 | 24 | 0.030 |
Why?
|
Cerebral Aqueduct | 1 | 1995 | 39 | 0.030 |
Why?
|
Germany | 1 | 2018 | 882 | 0.030 |
Why?
|
Collagen | 2 | 2002 | 2618 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2020 | 632 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13261 | 0.030 |
Why?
|
Recurrence | 2 | 2018 | 8498 | 0.030 |
Why?
|
Umbilical Cord | 1 | 2016 | 178 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2016 | 22224 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 1997 | 390 | 0.030 |
Why?
|
Rabbits | 1 | 2021 | 4733 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3539 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1788 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1193 | 0.030 |
Why?
|
Down-Regulation | 2 | 2005 | 2926 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1056 | 0.030 |
Why?
|
Gene Silencing | 1 | 2001 | 1505 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2012 | 855 | 0.030 |
Why?
|
Amino Acids | 1 | 2020 | 1709 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2001 | 2341 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2011 | 1696 | 0.030 |
Why?
|
Lectins | 2 | 1994 | 487 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5693 | 0.030 |
Why?
|
Term Birth | 1 | 2014 | 140 | 0.030 |
Why?
|
Solubility | 1 | 1995 | 1078 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2016 | 639 | 0.030 |
Why?
|
Age Factors | 1 | 2010 | 18375 | 0.030 |
Why?
|
Platelet Transfusion | 1 | 2016 | 296 | 0.030 |
Why?
|
Muramidase | 1 | 1973 | 163 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2018 | 568 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5787 | 0.030 |
Why?
|
Computational Biology | 2 | 2021 | 3558 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2017 | 550 | 0.030 |
Why?
|
Endothelium | 1 | 1995 | 768 | 0.030 |
Why?
|
Gene Deletion | 2 | 2016 | 2666 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1995 | 648 | 0.030 |
Why?
|
Dark Adaptation | 1 | 1994 | 224 | 0.030 |
Why?
|
Protein Kinase C | 1 | 1997 | 1202 | 0.030 |
Why?
|
Cognition | 1 | 2010 | 7048 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2001 | 2393 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 1984 | 2599 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2014 | 752 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 1996 | 901 | 0.030 |
Why?
|
Protein Binding | 2 | 2017 | 9299 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1997 | 1831 | 0.020 |
Why?
|
Cryotherapy | 1 | 2013 | 164 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7584 | 0.020 |
Why?
|
Mitomycins | 1 | 1992 | 45 | 0.020 |
Why?
|
Apoptosis | 1 | 2008 | 9511 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2018 | 1295 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2003 | 3313 | 0.020 |
Why?
|
Homeostasis | 1 | 2022 | 3336 | 0.020 |
Why?
|
Adrenal Cortex | 1 | 1992 | 134 | 0.020 |
Why?
|
Cataract | 2 | 1995 | 837 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2013 | 328 | 0.020 |
Why?
|
Protein Folding | 1 | 2015 | 868 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2002 | 2207 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2163 | 0.020 |
Why?
|
Survival Rate | 2 | 2022 | 12787 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8528 | 0.020 |
Why?
|
Mice, Nude | 1 | 2017 | 3614 | 0.020 |
Why?
|
Retinal Pigments | 1 | 2010 | 83 | 0.020 |
Why?
|
Models, Statistical | 2 | 2020 | 5088 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1999 | 2423 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6499 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15390 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2538 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 2015 | 587 | 0.020 |
Why?
|
Intercellular Junctions | 1 | 2010 | 198 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2002 | 5125 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2010 | 229 | 0.020 |
Why?
|
Time | 1 | 2011 | 550 | 0.020 |
Why?
|
Random Allocation | 1 | 1994 | 2393 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9647 | 0.020 |
Why?
|
Visual Pathways | 2 | 1984 | 555 | 0.020 |
Why?
|
Transcription Factors, TFII | 1 | 2009 | 62 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2119 | 0.020 |
Why?
|
Retinal Perforations | 1 | 2010 | 136 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2016 | 1043 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2393 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2010 | 341 | 0.020 |
Why?
|
Perfusion | 1 | 1994 | 1407 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 17062 | 0.020 |
Why?
|
Plant Lectins | 1 | 1988 | 103 | 0.020 |
Why?
|
Fetal Blood | 1 | 2015 | 1369 | 0.020 |
Why?
|
GATA2 Transcription Factor | 1 | 2009 | 158 | 0.020 |
Why?
|
Dendritic Spines | 1 | 2010 | 245 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1996 | 6109 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1185 | 0.020 |
Why?
|
Adenocarcinoma | 2 | 2002 | 6356 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2010 | 699 | 0.020 |
Why?
|
Half-Life | 1 | 2009 | 645 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5876 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2010 | 918 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39180 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2011 | 1525 | 0.020 |
Why?
|
Reference Values | 2 | 2006 | 4909 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2017 | 3404 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2010 | 1478 | 0.020 |
Why?
|
Morphogenesis | 1 | 2010 | 743 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6307 | 0.020 |
Why?
|
Brazil | 1 | 2010 | 1248 | 0.020 |
Why?
|
Biological Transport | 1 | 2010 | 2080 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 2013 | 1270 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3431 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4255 | 0.020 |
Why?
|
DNA Damage | 1 | 2016 | 2461 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2010 | 1178 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2010 | 2341 | 0.020 |
Why?
|
Picibanil | 1 | 2005 | 10 | 0.020 |
Why?
|
beta Catenin | 1 | 2010 | 1042 | 0.020 |
Why?
|
Adult | 7 | 2020 | 222974 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2009 | 569 | 0.020 |
Why?
|
Insulin | 1 | 1999 | 6601 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12056 | 0.010 |
Why?
|
Fibroblast Growth Factor 9 | 1 | 2004 | 13 | 0.010 |
Why?
|
Pigment Epithelium of Eye | 1 | 2005 | 209 | 0.010 |
Why?
|
Receptor, PAR-2 | 1 | 2004 | 34 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2011 | 1365 | 0.010 |
Why?
|
Acute Disease | 1 | 1995 | 7232 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3850 | 0.010 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2004 | 81 | 0.010 |
Why?
|
Eye Infections | 1 | 2005 | 63 | 0.010 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 1600 | 0.010 |
Why?
|
Cell Division | 1 | 1992 | 4472 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2011 | 3089 | 0.010 |
Why?
|
Middle Aged | 7 | 2020 | 222903 | 0.010 |
Why?
|
Optic Chiasm | 1 | 1984 | 89 | 0.010 |
Why?
|
Macaca | 1 | 2005 | 413 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1651 | 0.010 |
Why?
|
Exophthalmos | 1 | 2005 | 99 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 1995 | 4527 | 0.010 |
Why?
|
Suprachiasmatic Nucleus | 1 | 1984 | 141 | 0.010 |
Why?
|
Sclerotherapy | 1 | 2005 | 184 | 0.010 |
Why?
|
Cerebral Veins | 1 | 2005 | 157 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2004 | 254 | 0.010 |
Why?
|
Glucosamine | 2 | 1973 | 128 | 0.010 |
Why?
|
Abnormalities, Multiple | 2 | 2005 | 1424 | 0.010 |
Why?
|
Blepharoptosis | 1 | 2005 | 143 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17595 | 0.010 |
Why?
|
Chick Embryo | 1 | 2005 | 964 | 0.010 |
Why?
|
Cyclohexanes | 1 | 2003 | 151 | 0.010 |
Why?
|
Tritium | 2 | 1973 | 702 | 0.010 |
Why?
|
Neurofibromin 1 | 1 | 2004 | 189 | 0.010 |
Why?
|
Actins | 1 | 2010 | 2056 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1724 | 0.010 |
Why?
|
Pedigree | 1 | 2010 | 4524 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 812 | 0.010 |
Why?
|
Mice, Obese | 1 | 2003 | 417 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5781 | 0.010 |
Why?
|
Sesquiterpenes | 1 | 2003 | 175 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 24279 | 0.010 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2004 | 343 | 0.010 |
Why?
|
Phenylenediamines | 1 | 1983 | 89 | 0.010 |
Why?
|
Melanoma | 1 | 2001 | 5690 | 0.010 |
Why?
|
Receptors, Somatotropin | 1 | 2002 | 58 | 0.010 |
Why?
|
Endostatins | 1 | 2002 | 167 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2004 | 698 | 0.010 |
Why?
|
Cricetinae | 1 | 2005 | 2411 | 0.010 |
Why?
|
Pre-Eclampsia | 1 | 2011 | 1261 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2004 | 561 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2002 | 610 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10567 | 0.010 |
Why?
|
Edema | 1 | 2005 | 760 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2004 | 931 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3109 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2004 | 1885 | 0.010 |
Why?
|
Transgenes | 1 | 2003 | 1015 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2011 | 3140 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1995 | 12949 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2008 | 6203 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2004 | 1669 | 0.010 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2004 | 844 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2002 | 1679 | 0.010 |
Why?
|
Axons | 2 | 1984 | 1678 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1988 | 1559 | 0.010 |
Why?
|
Plasmids | 1 | 2003 | 2273 | 0.010 |
Why?
|
Adolescent | 3 | 2018 | 88781 | 0.010 |
Why?
|
Maleimides | 1 | 1997 | 112 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 4165 | 0.010 |
Why?
|
Patient Selection | 1 | 2009 | 4254 | 0.010 |
Why?
|
Binding Sites | 1 | 2004 | 6001 | 0.010 |
Why?
|
Hydrolysis | 2 | 1973 | 642 | 0.010 |
Why?
|
Tooth, Impacted | 1 | 1995 | 40 | 0.010 |
Why?
|
Acetamides | 2 | 1973 | 260 | 0.010 |
Why?
|
Cadherins | 1 | 1999 | 900 | 0.010 |
Why?
|
Cell Differentiation | 1 | 1992 | 11641 | 0.010 |
Why?
|
Chitin | 1 | 1973 | 34 | 0.010 |
Why?
|
Chemistry | 1 | 1973 | 325 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1973 | 483 | 0.010 |
Why?
|
Glycosides | 1 | 1973 | 99 | 0.010 |
Why?
|
Methods | 1 | 1973 | 1052 | 0.010 |
Why?
|
Mass Screening | 1 | 2009 | 5445 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 1995 | 550 | 0.010 |
Why?
|
Isoenzymes | 1 | 1997 | 1688 | 0.010 |
Why?
|
Hemorrhage | 1 | 2005 | 3461 | 0.010 |
Why?
|
Genomics | 1 | 2008 | 5924 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21478 | 0.010 |
Why?
|
Catalysis | 1 | 1973 | 770 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 1995 | 1105 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4624 | 0.010 |
Why?
|
Oligosaccharides | 1 | 1973 | 406 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59852 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36537 | 0.010 |
Why?
|
Kinetics | 2 | 1973 | 6272 | 0.000 |
Why?
|
Syndrome | 1 | 1995 | 3268 | 0.000 |
Why?
|
Skin | 1 | 2002 | 4474 | 0.000 |
Why?
|
Basement Membrane | 1 | 1988 | 348 | 0.000 |
Why?
|
Laminin | 1 | 1988 | 404 | 0.000 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1988 | 323 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 3717 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2002 | 8926 | 0.000 |
Why?
|
Drosophila melanogaster | 1 | 1973 | 1721 | 0.000 |
Why?
|
Neoplasms | 1 | 2011 | 22345 | 0.000 |
Why?
|
Epitopes | 1 | 1988 | 2523 | 0.000 |
Why?
|
Microscopy, Fluorescence | 1 | 1988 | 2626 | 0.000 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1983 | 938 | 0.000 |
Why?
|
Models, Structural | 1 | 1973 | 338 | 0.000 |
Why?
|
Carbon Radioisotopes | 1 | 1973 | 543 | 0.000 |
Why?
|
Molecular Conformation | 1 | 1973 | 541 | 0.000 |
Why?
|
Isotope Labeling | 1 | 1973 | 389 | 0.000 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1988 | 3640 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1973 | 2477 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1973 | 3054 | 0.000 |
Why?
|
Water | 1 | 1973 | 1418 | 0.000 |
Why?
|